Bayer shares plunge to a near two-decade low after blood thinner trial failureProactive Investors • 11/20/23
Bayer shares plunge by more than 20% after trial of potential blockbuster drug haltedMarket Watch • 11/20/23
Forrest Weldon Law Group Delivers Justice With $1.56 Billion Victory in Bayer Roundup TrialBusiness Wire • 11/19/23
Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial ContaminationBusiness Wire • 11/17/23
Bayer vows to cut ‘multiple layers of management' by end of 2024 as new CEO says firm's performance is ‘not acceptable'Market Watch • 11/08/23
Bayer and Broad Institute of MIT and Harvard Extend Research Collaboration to Develop New Cancer TherapiesBusiness Wire • 11/02/23
Fluor Completes Bayer's First Global Cell Therapy Launch Facility in Berkeley, CaliforniaBusiness Wire • 10/18/23
HALO Precision Diagnostics Collaborating with Bayer to Advance Contrast-Enhanced MRIBusiness Wire • 10/17/23
Bayer and Dollar General Partner to Increase Access to Fruit and Veggies, Celebrate National School Lunch WeekBusiness Wire • 10/11/23